Condition: Dermatitis Atopic · Sponsor: Sanofi
Primary Objective: To explore associations between biomarkers of atopic dermatitis (AD) and: * Disease state and time course of AD, * Disease state and evolution of selected atopic comorbid conditions, * Effectiveness of specific AD treatments.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| C Squared Research Center Site Number : 8400068 | Birmingham, Alabama, United States | — |
| Cahaba Dermatology Site Number : 8400046 | Birmingham, Alabama, United States | — |
| C2 Research Center, LLC Site Number : 8400071 | Montgomery, Alabama, United States | — |
| Axis Clinical Trials Site Number : 8400025 | Los Angeles, California, United States | — |
| Madera Family Medical Group Site Number : 8400054 | Madera, California, United States | — |
| Fomat Medical Research, Inc. Site Number : 8400033 | Oxnard, California, United States | — |
| Amedica Research Institute, Inc. Site Number : 8400067 | Hialeah, Florida, United States | — |
| Eastern Research, Inc. Site Number : 8400032 | Hialeah, Florida, United States | — |
| Vista Health Research, LLC Site Number : 8400034 | Miami, Florida, United States | — |
| Pediatric & Adult Research Center Site Number : 8400040 | Orlando, Florida, United States | — |
| Georgia Pollens Clinical Research Centers, Inc. Site Number : 8400057 | Albany, Georgia, United States | — |
| IACT Health Site Number : 8400056 | Columbus, Georgia, United States | — |
+ 36 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.